Steve Gavel serves as Chief Commercial Officer at Cabaletta Bio, Inc., where they oversee executive responsibilities. Since joining the company, Steve Gavel has executed 1 insider transactions totaling $50.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved purchasing 22,170 shares valued at $50.2K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | CABA | $50.2K | Purchase | 22,170 | $2.27 | Discretionary |
Steve Gavel currently holds 22,170 shares of Cabaletta Bio, Inc. (CABA), valued at approximately $0. This represents their equity stake as Chief Commercial Officer.
Based on SEC Form 4 filings, Steve Gavel has been a net buyer of CABA stock. They have purchased $50.2K and sold $0 worth of shares.
Steve Gavel's most recent insider trade was on Jan 21, 2026, when they purchased 22,170 shares at $2.27 per share.
Get notified when new Form 4 filings are submitted